Regulatory information – adjusted fees for pharmacovigilance applications to EMA from January 2018

December 22, 2017 – The European Medicines Agency reminds applicants and marketing authorisation holders that adjusted fees for pharmacovigilance applications are expected to come into effect in mid-January 2018. The European CommissionExternal link icon adopted a regulation adjusting the pharmacovigilance fees payable to the Agency on 18 October 2017. Following a two-month consultation with the Council and Parliament, the amended … (leggi tutto)